Jabbour, E., Kantarjian, H., O'Brien, S., Shan, J., Quintas-Cardama, A., Faderl, S., . . . Cortes, J. (2011). The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors. American Society of Hematology.

Jabbour, Elias, et al. The Achievement of an Early Complete Cytogenetic Response Is a Major Determinant for Outcome in Patients With Early Chronic Phase Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors. American Society of Hematology, 2011.

Jabbour, Elias, et al. The Achievement of an Early Complete Cytogenetic Response Is a Major Determinant for Outcome in Patients With Early Chronic Phase Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors. American Society of Hematology, 2011.